OBJECTIVE: Implementation of outpatient treatment (OT) of deep-vein thrombosis (DVT) is
slow despite clear evidence that it is effective, safe and cost-efficient. DESIGN AND …

Background Enoxaparin, a low-molecular-weight heparin administered to hospitalized
patients once or twice daily, has shown efficacy and safety equivalent to unfractionated …

Intravenous (IV) infusion of unfractionated heparin (UFH) followed by oral administration of
warfarin remains the cornerstone of clinical treatment of deep vein thrombosis (DVT) …

Although deep venous thrombosis (DVT) is now widely managed on an outpatient basis, at
a practical level there remains a potential for uncertainty as to which patient might prove …

In this study, 294 patients with acute proximal DVT (deep venous thrombosis) were
randomly assigned to receive intravenous standard heparin in the hospital (98 patients) or …

OBJECTIVE: To assess whether patients with deep vein thrombosis (DVT) could be
satisfactorily treated on an outpatient basis with low molecular weight (LMW) heparin and …

Purpose Compared with low-molecular-weight heparin (LMWH) and warfarin, the oral
anticoagulant rivaroxaban has advantages, such as simplified care, that may lead to less …

To address variation in treatment of deep vein thrombosis (DVT) while maximizing the
efficiency and quality of care, our institution developed a critical pathway guideline. This …

OBJECTIVE: To evaluate patient satisfaction, effectiveness, and safety of at-home treatment
of acute deep vein thrombosis (DVT) with subcutaneous enoxaparin dosed at 1.5 mg/kg …

Background It is uncertain whether patients with proximal deep-vein thrombosis should be
treated with streptokinase followed by intravenous heparin or with intravenous heparin …